SCHEMBL3862262

SCHEMBL3862262

OB(O)c1ccc(-c2cccc3c2oc2ccccc23)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 3/20 0.60
▸ GGPS1 O95749 1/20 0.44
▸ CA1 P00915 1/20 0.43
▸ CA2 P00918 1/20 0.43
▸ MGLL Q99685 1/20 0.43
▸ PRKDC P78527 5/20 0.41
▸ PTGES2 Q9H7Z7 1/20 0.41
▸ CDC14B O60729 2/20 0.37
▸ CDC14A Q9UNH5 2/20 0.37
▸ MAOA P21397 1/20 0.37
▸ PIK3CD O00329 1/20 0.37
▸ PIK3CB P42338 1/20 0.37
▸ ATM Q13315 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ PRMT5 O14744 1/20 0.36
▸ WDR77 Q9BQA1 1/20 0.36
▸ CA4 P22748 1/20 0.35
▸ CA6 P23280 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29427625 1.00 ALOX5 (0.60) ALOX5GGPS1CA1CA2MGLL
SCHEMBL20444575 0.91 ALOX5 (0.51) ALOX5GGPS1CA1CA2MGLL
SCHEMBL21924758 0.89 ALOX5 (0.50) ALOX5GGPS1CA1CA2MGLL
SCHEMBL23789613 0.88 ALOX5 (0.57) ALOX5GGPS1PRKDCPTGES2CDC14B
SCHEMBL24665207 0.87 MGLL (0.55) ALOX5CA1CA2MGLLPRKDC
SCHEMBL16582801 0.87 ALOX5 (0.70) ALOX5GGPS1PRKDCPTGES2CDC14B
SCHEMBL21102243 0.86 ALOX5 (0.58) ALOX5GGPS1MGLLPRKDCPTGES2
SCHEMBL25586142 0.86 ALOX5 (0.59) ALOX5GGPS1MGLLPRKDCPTGES2
SCHEMBL283154 0.85 ALOX5 (0.61) ALOX5GGPS1MGLLPRKDCPTGES2
SCHEMBL30980094 0.85 ALOX5 (0.61) ALOX5GGPS1MGLLPRKDCPTGES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025110448-A1 HETEROCYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE AND COMPOSITION FOR ORGANIC LAYER, EACH COMPRISING SAME 엘티소재주식회사 2025-05-30 — — WO disclosed
EP-4140990-B1 BENZO[B]NAPHTHO[2,1-D]FURAN COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME LT MATERIALS CO LTD (KR) 2025-03-19 — — EP disclosed
US-12030890-B2 Compounds with diazadibenzofurane or diazadibenzothiophene structures MERCK PATENT GMBH (DE) 2024-07-09 — — US disclosed
US-12030890-B2 Compounds with diazadibenzofurane or diazadibenzothiophene structures MERCK PATENT GMBH (DE) 2024-07-09 — — US disclosed
US-20240025872-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2024-01-25 — — US disclosed
US-20240025872-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2024-01-25 — — US disclosed
WO-2023213837-A1 CYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2023-11-09 — — WO disclosed
EP-3328841-B1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2023-10-11 — — EP disclosed
CN-116829552-A Compound, material for organic electroluminescent element, and electronic device 出光兴产株式会社 2023-09-29 — — CN disclosed
EP-4249478-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT Materials Co., Ltd. (KR) 2023-09-27 — — EP disclosed
US-20060094747-A1 Substituted carboxylic acids THE INSTITUTE FOR PHARMACEUTICAL DISCOVERY, L.L.C. 2006-05-04 — — US disclosed
EP-1628970-A2 HETEROCYCLE SUBSTITUTED CARBOXYLIC ACIDS AS INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE-1B The Institutes of Pharmaceutical Discovery, LLC (US) 2006-03-01 — — EP disclosed
EP-1622886-A2 SUBSTITUTED AMINO CARBOXYLIC ACIDS AS INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE-1B The Institutes for Pharmaceutical Discovery, LLC (US) 2006-02-08 — — EP disclosed
EP-1620422-A2 PHENYL SUBSTITUTED CARBOXYLIC ACIDS AS INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE-1B The Institutes for Pharmaceutical Discovery, LLC (US) 2006-02-01 — — EP disclosed
US-20050004369-A1 Phenyl substituted carboxylic acids INSTITUTES FOR PHARMACEUTICAL DISCOVERY, L.L.C. 2005-01-06 — — US disclosed
US-20050004114-A1 Heterocycle substituted carboxylic acids INSTITUTE FOR DIABETES DISCOVERY, L.L.C. 2005-01-06 — — US disclosed
US-20040266789-A1 Substituted amino carboxylic acids INSTITUTE FOR DIABETES DISCOVERY, L.L.C. 2004-12-30 — — US disclosed
WO-2004099171-A2 SUBSTITUTED AMINO CARBOXYLIC ACIDS AS INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE-1B THE INSTITUTES FOR PHARMACEUTICAL DISCOVERY, LLC (US) 2004-11-18 — — WO disclosed
WO-2004099170-A2 PHENYL SUBSTITUTED CARBOXYLIC ACIDS AS INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE-1B THE INSTITUTES FOR PHARMACEUTICAL DISCOVERY, LLC (US) 2004-11-18 — — WO disclosed
WO-2004099192-A2 HETEROCYCLE SUBSTITUTED CARBOXYLIC ACIDS AS INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE-1B THE INSTITUTES OF PHARMACEUTICAL DISCOVERY, LLC (US) 2004-11-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004114-A1 Heterocycle substituted carboxylic acids PTPRC, PTPRS, PTPRJ ALOX5 1318/4885GGPS1 2239/4885CA1 2211/4885
US-20060094747-A1 Substituted carboxylic acids PTPRS, PTPRO, PTPRJ ALOX5 1626/4885GGPS1 2090/4885CA1 1412/4885
US-12030890-B2 Compounds with diazadibenzofurane or diazadibenzothiophene structures DDT, ESD, DBF4 ALOX5 706/4885GGPS1 1259/4885CA1 3928/4885
US-20240025872-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1B1, CYP1A1 ALOX5 381/4885GGPS1 62/4885CA1 1891/4885
US-20050004369-A1 Phenyl substituted carboxylic acids PTPA, PTPRS, PTPRO ALOX5 1164/4885GGPS1 2760/4885CA1 2768/4885
US-20040266789-A1 Substituted amino carboxylic acids PTPRS, PPM1B, PTPRO ALOX5 1758/4885GGPS1 2583/4885CA1 2350/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback